Canton Hathaway, LLC Pfizer Inc Transaction History

Canton Hathaway, LLC

$366 Million
Q2 2024

A detailed history of Canton Hathaway, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Canton Hathaway, LLC holds 11,554 shares of PFE stock, worth $338,185. This represents 0.09% of its overall portfolio holdings.

Number of Shares

11,554

Previous 10,554 9.48%

Holding current value

$338,185

Previous $293,000 10.24%

% of portfolio

0.09%

Previous 0.08%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$25.26 - $29.6 $25,260 - $29,600	1,000 Added 9.48%	11,554 $323,000
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $77,670 - $89,190	3,000 Added 39.71%	10,554 $293,000
Q4 2023 Jan 30, 2024	BUY	$26.13 - $33.94 $130,650 - $169,700	5,000 Added 195.77%	7,554 $217,000
Q3 2023 Oct 11, 2023	BUY	$32.09 - $37.51 $18,708 - $21,868	583 Added 29.58%	2,554 $85,000
Q4 2022 Jan 19, 2023	BUY	$41.75 - $54.5 $1,670 - $2,180	40 Added 2.07%	1,971 $101,000
Q3 2022 Oct 17, 2022	SELL	$43.76 - $53.42 $37,196 - $45,407	-850 Reduced 30.56%	1,931 $85,000
Q3 2021 Oct 14, 2021	BUY	$39.25 - $50.42 $37,091 - $47,646	945 Added 51.47%	2,781 $120,000
Q2 2021 Jul 08, 2021	BUY	$35.91 - $40.68 $3,088 - $3,498	86 Added 4.91%	1,836 $72,000
Q1 2021 Apr 14, 2021	BUY	$33.49 - $37.77 $24,447 - $27,572	730 Added 71.57%	1,750 $63,000
Q4 2020 Feb 03, 2021	BUY	$33.47 - $42.56 $5,689 - $7,235	170 Added 20.0%	1,020 $38,000
Q1 2020 May 06, 2020	SELL	$27.03 - $38.62 $13,515 - $19,310	-500 Reduced 37.04%	850 $28,000
Q3 2019 Oct 11, 2019	SELL	$32.49 - $42.13 $25,504 - $33,072	-785 Reduced 36.77%	1,350 $49,000
Q2 2019 Jul 15, 2019	BUY	$36.98 - $41.52 $29,029 - $32,593	785 Added 58.15%	2,135 $92,000
Q3 2018 Oct 12, 2018	BUY	$34.47 - $41.81 $46,534 - $56,443	1,350 New	1,350 $59,000

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $164B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Canton Hathaway, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Canton Hathaway, LLC with notifications on news.

Account

Canton Hathaway, LLC Pfizer Inc Transaction History